tiprankstipranks
Trending News
More News >
Aptose Biosciences (TSE:APS)
TSX:APS
Canadian Market

Aptose Biosciences (APS) Cash flow

Compare
146 Followers

Aptose Biosciences Cash Flow

TSE:APS's free cash flow for Q3 2025 was $-7.41M. For the 2025 fiscal year, TSE:APS's free cash flow was decreased by $8.64M and operating cash flow was $-7.41M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -35.98M$ -44.59M$ -32.32M$ -43.30M$ -33.89M
Investing Cash Flow
$ 18.00K$ 9.96M$ 30.07M$ -35.21M$ 12.63M
Financing Cash Flow
$ 33.41M$ 6.91M$ 116.00K$ 226.00K$ 58.81M
End Cash Position
$ 6.71M$ 9.25M$ 36.97M$ 39.11M$ 117.39M
Free Cash Flow
$ -35.98M$ -44.62M$ -32.35M$ -43.52M$ -33.97M
Currency in USD

Aptose Biosciences Cash Flow